SKLADANY, Lubomir, Marian OLTMAN, Sona FRANKOVA, Sylvia DRAZILOVA, Petr HUSA, Jan SPERL, Vaclav HEJDA, Petr URBANEK, Svetlana ADAMCOVA-SELCANOVA, Martin JANICKO, Pavol KRISTIAN, Viera KUPCOVA, Marek RAC, Ivan SCHRETER, Ladislav VIRAG, Adriana LIPTAKOVA, Miriam ONDRASOVA a Peter JARCUSKA. Chronic hepatitis C virus infection in the Czech Republic and Slovakia: an analysis of patient and virus characteristics. International Journal of Public Health. Basel (Switzerland): Springer, 2020, roč. 65, č. 9, s. 1723-1735. ISSN 1661-8556. Dostupné z: https://dx.doi.org/10.1007/s00038-020-01496-y.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Chronic hepatitis C virus infection in the Czech Republic and Slovakia: an analysis of patient and virus characteristics
Autoři SKLADANY, Lubomir (703 Slovensko), Marian OLTMAN (703 Slovensko, garant), Sona FRANKOVA (203 Česká republika), Sylvia DRAZILOVA (703 Slovensko), Petr HUSA (203 Česká republika, domácí), Jan SPERL (203 Česká republika), Vaclav HEJDA (203 Česká republika), Petr URBANEK (203 Česká republika), Svetlana ADAMCOVA-SELCANOVA (703 Slovensko), Martin JANICKO (703 Slovensko), Pavol KRISTIAN (703 Slovensko), Viera KUPCOVA (703 Slovensko), Marek RAC (203 Česká republika), Ivan SCHRETER (203 Česká republika), Ladislav VIRAG (703 Slovensko), Adriana LIPTAKOVA (703 Slovensko), Miriam ONDRASOVA (703 Slovensko) a Peter JARCUSKA (203 Česká republika).
Vydání International Journal of Public Health, Basel (Switzerland), Springer, 2020, 1661-8556.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30304 Public and environmental health
Stát vydavatele Švýcarsko
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 3.380
Kód RIV RIV/00216224:14110/20:00116718
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1007/s00038-020-01496-y
UT WoS 000576627700002
Klíčová slova anglicky Chronic HCV infection; HCV genotype; HCV liver disease; Czech Republic; Slovakia; Anti-HCV therapy
Štítky 14110214, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Tereza Miškechová, učo 341652. Změněno: 5. 1. 2021 13:35.
Anotace
Objectives The MOSAIC study gathered data on chronic hepatitis C virus (HCV) infection and its treatment in various countries worldwide. Here we summarise patient and HCV characteristics in the Czech Republic and Slovakia. Methods MOSAIC was an observational study that included patients with chronic HCV infection untreated at the time of enrolment. Study collected and descriptively analysed patient demographics, disease stage and viral characteristics. Data were collected between February 2014 to October 2014. Results Among 220 patients enrolled, 51.4% were treatment-naive. The most prevalent HCV genotype was G1 (78.4%), followed by G3 (19.7%). Higher prevalence of G1 was found in treatment-experienced patients (94.3%) compared to treatment-naive (63.4%). Most participants (67.7%) presented viral RNA load of >= 800,000 IU/mL. Liver cirrhosis was reported in 24.5% of patients. Higher HCV RNA load and duration of HCV infection correlated with the degree of liver fibrosis. Anti-HCV interferon-based treatments were initiated in 88.2% of participants. Conclusions The study confirmed significant changes in the HCV genotypes partition with G3 genotype rapidly increasing in both countries, with possible impact on the WHO eradication initiative and treatment selection.
VytisknoutZobrazeno: 21. 5. 2024 16:45